Manchester United and the Sesko Problem: When Carrick Must Build on Sand

In the second half of the Carabao Cup tie against Brighton, on his third consecutive sprint, Benjamin Sesko slowed down. He did not fall, did not need a stretcher, gave no medical signal clear enough on the pitch for the referee to stop play. Three days later, his name vanished from the matchday squad against Fulham. This is the most awkward type of injury in modern football: it does not sit on the long-term list, yet it gives nobody a return date. Michael Carrick addressed the media with exactly the vagueness a head coach tends to use when the medical room has not settled on an answer: "We're not sure with Ben yet. He felt a bit of pain after the game." As someone who has spent years dissecting hundreds of incidents on tape, I am used to making decisions with incomplete information, and equally used to being wrong for guessing too fast.

Sesko is 23, a Slovenia international, viewed as Manchester United's central forward option. The name carries a heavy injury file: absent for the final three games of last season, out for the entire pre-season, more than two months without playing. Early this season he returned, started against Brighton, then suffered a recurrence of the same shin problem.

Beside that sits a wider personnel picture. Matthijs de Ligt travelled with the squad but was not fit enough to be included. Amad Diallo has not played a minute this season. Carlos Baleba, a summer signing, has just made his first bench appearance. Cole Palmer withdrew from England duty for the Nations League fixtures. Marcus Rashford and Kobbie Mainoo were called up. Carrick summed up the situation in one short line: "Not many positives right now." The coming international break is both a recovery window and a trap named the FIFA virus, the risk of players returning tired or newly injured.

Analyse fitness and availability first, tactics second. Sesko has made only six appearances in all competitions this season. That sample is too small to judge form, but large enough to reveal a pattern: recurring injury in the same area within a few months. In sports medicine, recurrence is not a random event. It is a signal that load has not been managed correctly, or that the underlying damage had not fully healed before the player was pushed back into matches. When data enters the dressing room, emotion must leave through the window, and the data here says one thing: six games is too thin for anyone to judge form, but dense enough to recognise a pattern of recurrence.

For Carrick, the consequences are a chain reaction. The centre-forward position is the axis every attacking plan leans on. When that axis wobbles, the coach must choose between two costly paths: use a backup striker of lower quality, or push an attacking midfielder into a false nine. The false nine is no bad tactical solution; it opens space for the second line, shifts the landing point of the final pass, drags opposing centre-backs out of the box. But it demands training time and chemistry between the links, and a patched-up side does not have that.

No team can build an attacking system around a centre-forward whose medical staff cannot yet confirm a return date. That is what Carrick must accept. He cannot plan substitutions around whether Sesko can last 70 minutes. He cannot allocate minutes to the alternatives if those alternatives are not fit themselves. De Ligt is not in the squad, Amad has no minutes. Three variables at once shrink rotation to an alarm level.

Baleba's first bench appearance is the single positive signal in this picture. A new central midfielder can give Carrick a rotation option in midfield, easing the load on players forced to grind through every match. But one bench appearance does not create squad depth. It is only the first step of integration, a process that usually takes four to eight weeks before a player is fit enough and fluent enough in the system.

Notably, Rashford and Mainoo were called up by England. On the surface, that is a signal of squad quality, evidence that Manchester United still own players of international standard. Behind it lies a familiar problem: minutes with the national team plus travel create risk the club cannot control. Cole Palmer's withdrawal from England is the inverse example, a different player choosing to stay behind and manage his condition. The difference between these two choices is not the severity of injury; it is how each club and each player prices risk.

Argue against myself. The picture the media paints is quite clear: a team beaten in a cup, a striker whose injury has recurred, a coach admitting there are not many positives. The temptation is to name a culprit, whether Carrick, the medical room, or the recruitment department.

But the data sample here is far too thin to convict anyone. Six appearances and one recurrence are not enough to judge a club's medical competence. In refereeing, I learned that a single mistake can decide a match, but is not enough to judge that referee's ability. You need a larger sample, cross-checks, context. The camera finds the error, but only a human finds the cause. The same incident, ten camera angles, ten different readings, and the most popular reading is not necessarily the correct one.

What deserves more debate sits elsewhere: how clubs price injury risk. A 23-year-old in his appreciation phase is signed with a known injury record. The most valuable contract is usually the one never made public, the one that spells out condition-related clauses, minimum appearances, and the right to renegotiate if the injury recurs. The biggest mistake is not signing an injury-prone player; it is failing to price that risk from the start.

The international break will answer more questions than any press conference. If Sesko returns and is load-managed on a clear plan, Manchester United can pivot their attack back into shape. If the injury is confirmed as chronic, the problem shifts from tactics to structure, and the thing to fix will not be the formation, but the way the club buys, protects and uses its assets.